COMBINATION OF MUPIROCIN WITH PORPHYRIN-BASED PHOTOSENSITIZERS FOR REDUCING ANTIBIOTIC RESISTANCE EMERGENCE
There is provided a use of a compound of formula (I) or formula (II) as defined herein to suppress the emergence of antibiotic resistance in bacteria exposed to another antibacterial agent (e.g. mupirocin). There is also provided a combination comprising a compound of formula (I) or formula (II) as...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RHYS-WILLIAMS, William LOVE, William G |
| description | There is provided a use of a compound of formula (I) or formula (II) as defined herein to suppress the emergence of antibiotic resistance in bacteria exposed to another antibacterial agent (e.g. mupirocin). There is also provided a combination comprising a compound of formula (I) or formula (II) as defined herein and a second antibacterial agent (e.g. mupirocin) for treating or preventing a bacterial infection, in which the use of the combination suppresses the emergence of antibiotic resistance. Such bacterial infections may be caused by Staphylococcus aureus or Streptococcus pyogenes, e.g. MRSA.
L'invention concerne l'utilisation d'un composé de formule (I) ou de formule (II) telles que définies ici pour inhiber l'émergence d'une résistance aux antibiotiques dans des bactéries exposées à un autre agent antibactérien (par exemple la mupirocine). L'invention concerne également une combinaison comprenant un composé de formule (I) ou de formule (II) telles que définies dans la description et un second agent antibactérien (par exemple la mupirocine) pour traiter ou prévenir une infection bactérienne, dans laquelle l'utilisation de la combinaison inhibe l'émergence d'une résistance aux antibiotiques. De telles infections bactériennes peuvent être provoquées par Staphylococcus aureus ou Streptococcus pyogenes, par exemple le MRSA. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022180380A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022180380A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022180380A13</originalsourceid><addsrcrecordid>eNqNi7sKwkAQRdNYiPoPA9aBPJq0m80kO0V2lt0JQZsQZG0UDcT_xxR-gNU9HM7dJw_NfU1WCbEFbqEfHHnWZGEkMeDYO3PxZNNaBWzAGRYOaAMJXdEHaNmDx2bYHh0oK1QTC-nNBQqirEbAHn2HGx2T3X1-rvH020NyblG0SePynuK6zLf4ip9p5CIrirzKyipTeflf9QUNAzgO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION OF MUPIROCIN WITH PORPHYRIN-BASED PHOTOSENSITIZERS FOR REDUCING ANTIBIOTIC RESISTANCE EMERGENCE</title><source>esp@cenet</source><creator>RHYS-WILLIAMS, William ; LOVE, William G</creator><creatorcontrib>RHYS-WILLIAMS, William ; LOVE, William G</creatorcontrib><description>There is provided a use of a compound of formula (I) or formula (II) as defined herein to suppress the emergence of antibiotic resistance in bacteria exposed to another antibacterial agent (e.g. mupirocin). There is also provided a combination comprising a compound of formula (I) or formula (II) as defined herein and a second antibacterial agent (e.g. mupirocin) for treating or preventing a bacterial infection, in which the use of the combination suppresses the emergence of antibiotic resistance. Such bacterial infections may be caused by Staphylococcus aureus or Streptococcus pyogenes, e.g. MRSA.
L'invention concerne l'utilisation d'un composé de formule (I) ou de formule (II) telles que définies ici pour inhiber l'émergence d'une résistance aux antibiotiques dans des bactéries exposées à un autre agent antibactérien (par exemple la mupirocine). L'invention concerne également une combinaison comprenant un composé de formule (I) ou de formule (II) telles que définies dans la description et un second agent antibactérien (par exemple la mupirocine) pour traiter ou prévenir une infection bactérienne, dans laquelle l'utilisation de la combinaison inhibe l'émergence d'une résistance aux antibiotiques. De telles infections bactériennes peuvent être provoquées par Staphylococcus aureus ou Streptococcus pyogenes, par exemple le MRSA.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&CC=WO&NR=2022180380A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&CC=WO&NR=2022180380A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RHYS-WILLIAMS, William</creatorcontrib><creatorcontrib>LOVE, William G</creatorcontrib><title>COMBINATION OF MUPIROCIN WITH PORPHYRIN-BASED PHOTOSENSITIZERS FOR REDUCING ANTIBIOTIC RESISTANCE EMERGENCE</title><description>There is provided a use of a compound of formula (I) or formula (II) as defined herein to suppress the emergence of antibiotic resistance in bacteria exposed to another antibacterial agent (e.g. mupirocin). There is also provided a combination comprising a compound of formula (I) or formula (II) as defined herein and a second antibacterial agent (e.g. mupirocin) for treating or preventing a bacterial infection, in which the use of the combination suppresses the emergence of antibiotic resistance. Such bacterial infections may be caused by Staphylococcus aureus or Streptococcus pyogenes, e.g. MRSA.
L'invention concerne l'utilisation d'un composé de formule (I) ou de formule (II) telles que définies ici pour inhiber l'émergence d'une résistance aux antibiotiques dans des bactéries exposées à un autre agent antibactérien (par exemple la mupirocine). L'invention concerne également une combinaison comprenant un composé de formule (I) ou de formule (II) telles que définies dans la description et un second agent antibactérien (par exemple la mupirocine) pour traiter ou prévenir une infection bactérienne, dans laquelle l'utilisation de la combinaison inhibe l'émergence d'une résistance aux antibiotiques. De telles infections bactériennes peuvent être provoquées par Staphylococcus aureus ou Streptococcus pyogenes, par exemple le MRSA.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7sKwkAQRdNYiPoPA9aBPJq0m80kO0V2lt0JQZsQZG0UDcT_xxR-gNU9HM7dJw_NfU1WCbEFbqEfHHnWZGEkMeDYO3PxZNNaBWzAGRYOaAMJXdEHaNmDx2bYHh0oK1QTC-nNBQqirEbAHn2HGx2T3X1-rvH020NyblG0SePynuK6zLf4ip9p5CIrirzKyipTeflf9QUNAzgO</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>RHYS-WILLIAMS, William</creator><creator>LOVE, William G</creator><scope>EVB</scope></search><sort><creationdate>20220901</creationdate><title>COMBINATION OF MUPIROCIN WITH PORPHYRIN-BASED PHOTOSENSITIZERS FOR REDUCING ANTIBIOTIC RESISTANCE EMERGENCE</title><author>RHYS-WILLIAMS, William ; LOVE, William G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022180380A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RHYS-WILLIAMS, William</creatorcontrib><creatorcontrib>LOVE, William G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RHYS-WILLIAMS, William</au><au>LOVE, William G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION OF MUPIROCIN WITH PORPHYRIN-BASED PHOTOSENSITIZERS FOR REDUCING ANTIBIOTIC RESISTANCE EMERGENCE</title><date>2022-09-01</date><risdate>2022</risdate><abstract>There is provided a use of a compound of formula (I) or formula (II) as defined herein to suppress the emergence of antibiotic resistance in bacteria exposed to another antibacterial agent (e.g. mupirocin). There is also provided a combination comprising a compound of formula (I) or formula (II) as defined herein and a second antibacterial agent (e.g. mupirocin) for treating or preventing a bacterial infection, in which the use of the combination suppresses the emergence of antibiotic resistance. Such bacterial infections may be caused by Staphylococcus aureus or Streptococcus pyogenes, e.g. MRSA.
L'invention concerne l'utilisation d'un composé de formule (I) ou de formule (II) telles que définies ici pour inhiber l'émergence d'une résistance aux antibiotiques dans des bactéries exposées à un autre agent antibactérien (par exemple la mupirocine). L'invention concerne également une combinaison comprenant un composé de formule (I) ou de formule (II) telles que définies dans la description et un second agent antibactérien (par exemple la mupirocine) pour traiter ou prévenir une infection bactérienne, dans laquelle l'utilisation de la combinaison inhibe l'émergence d'une résistance aux antibiotiques. De telles infections bactériennes peuvent être provoquées par Staphylococcus aureus ou Streptococcus pyogenes, par exemple le MRSA.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022180380A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMBINATION OF MUPIROCIN WITH PORPHYRIN-BASED PHOTOSENSITIZERS FOR REDUCING ANTIBIOTIC RESISTANCE EMERGENCE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A23%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RHYS-WILLIAMS,%20William&rft.date=2022-09-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022180380A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |